Summary
Overview
Work History
Education
Skills
Publications
Timeline
Generic

Allen Bosley

Riva,Maryland

Summary

Enthusiastic team leader with unique experience in research, CMC (conception through commercialization of biologics) and regulatory matters aiming at improving patients' lives.

Overview

27
27
years of professional experience

Work History

Research Assistant

University of Maryland Baltimore County
  • Lab scientist who explored novel yeast cell growth media to improve cell wall integrity, allowing for greater agitation and oxygenation during fermentation, and ultimately improving protein expression

Associate Director

AstraZeneca
03.2020 - Current
  • CMC Project Lead for an early stage asset, pioneering technical and business processes (continuous processing end-to-end for clinical production), leveraging external and internal CMC focused working groups

Scientist II

AstraZeneca (Medimmune)
06.2017 - 03.2020
  • Downstream CMC representative for Saphnelo and Adbry/Adtralza through process characterization, validation, global regulatory submissions and responses

Scientist I

AstraZeneca (Medimmune)
03.2014 - 06.2017
  • Lead scientist in the development a scale-down model for process intermediate hold time characterization, which replicates storage conditions at the manufacturing site, and developed a template protocol for the execution of characterization studies

Research Scientist II

NCI-Frederick
06.2008 - 03.2014
  • Lead researcher in the development and optimization of protein purification methods enabling the identification and validation of protein-protein and protein-DNA interactions

Post-doctoral Research Fellow

NCI-Frederick
03.2007 - 06.2008
  • Project lead exploring changes in human plasma protein levels of HIV patients over the course of disease progression by using HPLC to deplete abundant proteins and Time-of-Flight Mass Spectrometry to quantify proteins of interest

Graduate Student / Post-Doc

Johns Hopkins University
09.2001 - 02.2007
  • Graduate student lead for a project using recombinant DNA technology for the construction of protein libraries
  • Developed assays for the selection of proteins with desired properties

Manufacturing Engineer

Perkin Elmer Fluid Sciences
12.2000 - 08.2001
  • Design engineer for tooling used to manufacture custom ordered metallic seals

Engineering Intern

Perkin Elmer Fluid Sciences
02.1997 - 12.2000
  • One of only two interns supporting the entire Metallic Seal Business unit in seal and tooling design, as well as metal plating

Education

Doctor of Philosophy - Chemical and Biomolecular Engineering

Johns Hopkins University
Baltimore, MD
09.2006

Bachelor of Science - Chemical Engineering

University of Maryland Baltimore County
Baltimore, MD
12.2000

Skills

  • Expert in cross functional CMC matters (from early process development though validation and commercialization), with deeper knowledge on purification, technology transfer, and regulatory submission delivery
  • Experienced matrix manager of large high performing teams delivering innovative solutions
  • Exceptional communicator (demonstrated through project lead experience, contributions to global regulatory submissions, and publications)
  • Effective strategist, driving improved efficiency through solid analytical reasoning

Publications

  • Process Development and Characterization for Integrated Continuous Bioprocesses – Highlights from N-mAb, K. Brower, K. Wiltberger, C. Berdugo, A Bosley, E. Goodrich, V. Pferdeort, G. Shaefer, Biotechnology Progress, 2024
  • Managing Integrated Continuous Bioprocess in Real Time: Deviations in Product Quality, G. Grampp, A. Bosley, M. Qadan, J. Schiel, A. Spasoff, P. Valax, G. Shaefer, Biotechnology Progress, 2023
  • Improved Process Intermediate Stability Through the Identification and Elimination of reactive Glycation Residues- A Monoclonal Antibody Case study., A. Bosley, K. Cook, S. Lin, D. Robbins, Bioengineered, 2022
  • N-mAb A Case Study to Support Development and Adoption of the Integrated Continuous Bioprocesses for Monoclonal Antibodies., 55 authors representing 22 organizations (Industry, government, and academia), National Institute for Innovation in Manufacturing Biopharmaceuticals, 2022
  • Kinetic Modeling as a Tool to Understand the Influence of Cell Culture Process Parameters on the Glycation of Monoclonal Antibody Biotherapeutics, N. Agarwal, A. Mason, R. Pradhan, J. Kemper, A. Bosley, D. Serfiotis-Mitsa, J. Wang, V. Lindo, S. Ahuja, D. Hatton, J. Savery, G. Miro-Quesada, Biotechnology Progress, 2019
  • CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells., J. Jia, A.D. Bosley, A. Thompson, J. Hoskins, A. Cheuk, I. Collins, H. Parikh, Z. Xiao, K. Ylaya, M. Dzyadyk, W. Cozen, B. Hernandez, C. Lynch, S.F. Altekruse, L. Zhang, C.J. Westlake, V.M. Factor, S.Thorgeirsson, W.Bamlet, S.M. Hewitt, J. Khan, G. Petersen, T. Andresson, L.T. Amundadottir, Cancer Research, 2014
  • SIRT3 Deacetylates ATP Synthase F1 Complex Proteins in Response to Nutrient and Exercise-Induced Stress., A. Vassilopoulos, J.D. Pennington, T. Andresson, D. Rees, A.D. Bosley, I.M. Fearnley, A. Ham, C.R. Flynn, S. Hill, K.L. Rose, H. Kim, C. Deng, J. Walker, D. Gius, Antioxidants and Redox Signaling, 2013
  • BRD4 Short Isoform Interacts with RRP1B, SIPA1 and Components of the LINC Complex at the Inner Face of the Nuclear Membrane., J. Alsarraj, F. Faraji, T.R. Geiger, K.R. Mattaini, M. Williams, J. Wu, N.Ha, T. Merlino, R.C. Walker, A.D. Bosley, Z. Xiao, T. Andresson, D. Esposito, N. Smithers, D. Lugo, R. Prinjha, A. Day, N.P.S. Crawford, K. Ozato, K. Gardner, K.W. Hunter, PLOS ONE, 2013
  • A Role for Protein–Protein Interaction Networks in the Identification and Characterization of Potential Biomarkers., A.D. Bosley, S. Das, T. Andresson, Proteomic and Metabolomic Approaches to Biomarker Discovery (Book Chapter), 2013
  • The UBIAD1 prenyltransferase links menaquinone-4 synthesis to cholesterol metabolic enzymes., M.L. Nickerson, A.D. Bosley, J.S. Weiss, B.N. Kostiha, Y. Hirota, W. Brandt, D. Esposito, S. Kinoshita, L. Wessjohann, S.G. Morham, T. Andresson, H.S. Kruth, T. Okano, M. Dean, Human Mutatation, 2013
  • Comparison of strong cation exchange and SDS-PAGE fractionation for analysis of multiprotein complexes., S. Das, A.D. Bosley, Ye X, K.C. Chan, I Chu, J.E. Green, H.J. Issaq, T.D. Veenstra, T. Andresson, J Proteome Res., 2010
  • A method of HIV-1 inactivation compatible with antibody based depletion of abundant proteins from plasma, A. Bosley, H. N. Marshall, Y. Badralmaa, V. Natarajan, Proteomics-Clinical Application, 2008
  • A bacterial one-hybrid system for interrogating Zinc Finger-DNA interactions., S. Durai, A. D. Bosley, A.B. Abulencia, S. Chandrasegaran, M. Ostermeier, Combinatorial Chemistry and High Throughput Screening, 2006
  • Mathematical expressions useful in the construction, description and evaluation of protein libraries., A. Bosley, M. Ostermeier, Biomolecular Engineering, 2005

Timeline

Associate Director

AstraZeneca
03.2020 - Current

Scientist II

AstraZeneca (Medimmune)
06.2017 - 03.2020

Scientist I

AstraZeneca (Medimmune)
03.2014 - 06.2017

Research Scientist II

NCI-Frederick
06.2008 - 03.2014

Post-doctoral Research Fellow

NCI-Frederick
03.2007 - 06.2008

Graduate Student / Post-Doc

Johns Hopkins University
09.2001 - 02.2007

Manufacturing Engineer

Perkin Elmer Fluid Sciences
12.2000 - 08.2001

Engineering Intern

Perkin Elmer Fluid Sciences
02.1997 - 12.2000

Research Assistant

University of Maryland Baltimore County

Doctor of Philosophy - Chemical and Biomolecular Engineering

Johns Hopkins University

Bachelor of Science - Chemical Engineering

University of Maryland Baltimore County
Allen Bosley